Diabetes
- How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
Hemoglobin A1c is the standard but is not perfect. Alternatives are available.
- The role of SGLT-2 inhibitors in managing type 2 diabetes
These drugs improve glycemic control and offer cardiovascular and metabolic benefits.
- SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
Randomized controlled trials of these new agents had positive outcomes.
- Peripheral artery disease and unusual skin findings
A 68-year-old man was admitted because of worsening skin problems in his legs.
- Aspirin for primary prevention of atherosclerotic cardiovascular events
A more limited role for aspirin as primary prevention in patients at intermediate risk, with diabetes, and the elderly.
- Type of diabetes mellitus: Does it matter to the clinician?
Understanding the many faces of diabetes can make a difference in how clinicians select glucose-lowering therapy.